Exclusive: U.S. health regulator Verma eyes new methods for drug pricing

NEW YORK (Reuters) - The U.S. government is considering setting new payment methods aimed at curbing costs for Medicare and Medicaid coverage of breakthrough medical treatments with very high prices, particularly novel gene-based therapies for cancer and other diseases, a top health official said on Thursday.

from Reuters: U.S. http://ift.tt/2j2PrNa